Patient Name : Mr.

M RAMESH Organization : SANJEEVANI CLINIC

Age / Gender : 58y / Male Sample ID : 250250174h
Referred By : DR.SRINIVAS .K.MD Registered : Jan 25, 2025, 12:10 p.m.
Reg No : 1001782 Received On : Jan 25, 2025, 12:11 p.m.
Sample Type : EDTA Approved On : Jan 25, 2025, 01:11 p.m.

HEMATOLOGY

COMPLETE BLOOD PICTURE (CBP)

TEST NAME(s) RESULTS UNITS REFERANCE RANGE

HAEMOGLOBIN* 15.7 gm/dL 13.0 - 17.0

Method : SLS Hemoglobin

PCV (HAEMATOCRIT) 46.6 % 40 - 50

Method : RBC Pulse height detection

RBC COUNT* 5.37 Mill/cumm 4.5 - 5.5

Method : Hydrodynamic focus DC detection

WBC COUNT* 6660 cell/cumm 4000 - 10000

Method : Flow Cytometry/Microscopy

PLATELET COUNT 2.45 lakhs/cumm 1.5 - 4.1

Method : Hydrodynamic focus DC detection

DIFFERENTIAL COUNT

NEUTROPHILS 58 % 40 - 80

LYMPHOCYTES 27 % 20 - 40

MONOCYTES 07 % 2-8

EOSINOPHILS 08 % 1-6

BASOPHILS 0 % 0-1

PERIPHERAL SMEAR

RBC : Normocytic Normochromic

WBC : Eosinophilia

PLATELET : Adequate

METHOD : Automated cell Counter + Microscopy

Note : -

Checked By: SRINIVAS CHOUHAN

Lab Technician
______________________________________________________________________________________________________________________
**END OF REPORT**

Printed On: Jan 25, 2025, 04:54 p.m. Page 1 of 9

Patient Name : Mr. M RAMESH Organization : SANJEEVANI CLINIC
Age / Gender : 58y / Male Sample ID : 250250174h
Referred By : DR.SRINIVAS .K.MD Registered : Jan 25, 2025, 12:10 p.m.
Reg No : 1001782 Received On : Jan 25, 2025, 12:11 p.m.
Sample Type : EDTA Approved On : Jan 25, 2025, 01:11 p.m.

Please Corelate With Clinical Findings If Necessary Discuss | * This is an Electronically Authenticated Report *

Printed On: Jan 25, 2025, 04:54 p.m. Page 2 of 9

Patient Name : Mr. M RAMESH Organization : SANJEEVANI CLINIC
Age / Gender : 58y / Male Sample ID : 250250174F
Referred By : DR.SRINIVAS .K.MD Registered : Jan 25, 2025, 12:10 p.m.
Reg No : 1001782 Received On : Jan 25, 2025, 12:11 p.m.
: PLASMA - F
Sample Type Approved On : Jan 25, 2025, 03:37 p.m.

CLINICAL BIOCHEMISTRY

FASTING BLOOD GLUCOSE (FBS)

TEST NAME(s) RESULTS UNITS REFERANCE RANGE

FASTING BLOOD GLUCOSE (FBS) 99.8 mg/dL 70 - 100

Method : GODPOD Impaired Fasting: 100 - 125

Interpretations
A healthy (normal) fasting blood glucose level for someone without diabetes is 70 to 99 mg/dL. Values between 50 and 70 mg/dL for people without diabetes
can be “normal” too.

Checked By: K.VIJAY KUMAR

Lab Technician
______________________________________________________________________________________________________________________
**END OF REPORT**
Please Corelate With Clinical Findings If Necessary Discuss | * This is an Electronically Authenticated Report *

Printed On: Jan 25, 2025, 04:54 p.m. Page 3 of 9

Patient Name : Mr. M RAMESH Organization : SANJEEVANI CLINIC
Age / Gender : 58y / Male Sample ID : 250250174h
Referred By : DR.SRINIVAS .K.MD Registered : Jan 25, 2025, 12:10 p.m.
Reg No : 1001782 Received On : Jan 25, 2025, 12:11 p.m.
Sample Type : EDTA Approved On : Jan 25, 2025, 03:31 p.m.

CLINICAL BIOCHEMISTRY

GLYCOSYLATED HAEMOGLOBIN (GHB / HBA1C)

TEST NAME(s) RESULTS UNITS REFERANCE RANGE

GLYCOSYLATED HAEMOGLOBIN (HB A1C) 5.5 % Non Diabetics : 4.0% - 6.0%,

Method : HPLC (High Performance Liquid Chromatography) Diabetes Range: 6.0% - 8.0%

ESTIMATED AVERAGE GLUCOSE (EAG) 121 mg/dL -

Method : Calculated
INTERPRETATION
Significance of the HbA1c Test:
HbA1c is an excellent index of long term diabetes control - over preceding 2 - 3 months. Unlike blood sugars which tend to fluctuate
from day to day and even hour to hour, the HbA1c test is a true index of the average blood glucose control during previous 2 - 3
months. HbA1c test is done in this laboratory precisely using HPLC, the "Gold Standard" of HbA1c testing. It is recommended hence
that HbA1c be monitored in diabetics at least every 3 months.
Estimated Average Glucose:
Estimated Average Glucose (eAG) is a new way to understand how well you are managing your diabetes. HbA1c is reported as a
percent. Estimated average glucose, or eAG uses the same units (mg/dL) as the blood glucose level.
Reference: American Diabetes Association (www.diabetes.org)

Checked By: K.VIJAY KUMAR

Lab Technician
______________________________________________________________________________________________________________________
**END OF REPORT**
Please Corelate With Clinical Findings If Necessary Discuss | * This is an Electronically Authenticated Report *

Printed On: Jan 25, 2025, 04:54 p.m. Page 4 of 9

Patient Name : Mr. M RAMESH Organization : SANJEEVANI CLINIC
Age / Gender : 58y / Male Sample ID : 250250174
Referred By : DR.SRINIVAS .K.MD Registered : Jan 25, 2025, 12:10 p.m.
Reg No : 1001782 Received On : Jan 25, 2025, 12:12 p.m.
Sample Type : SERUM Approved On : Jan 25, 2025, 03:32 p.m.

CLINICAL BIOCHEMISTRY

LIPID PROFILE (LPD)

TEST NAME(s) RESULTS UNITS REFERANCE RANGE

TOTAL CHOLESTEROL 181.4 mg/dL Desirable : < 200

Method : CHOD,POD Borderline: 200 - 239
High Risk : > 239

HDL CHOLESTEROL 36.28 mg/dL 35.3 - 79.5

Method : Direct Measurement, PEG

LDL CHOLESTEROL 112.66 mg/dL Less than 100 mg/dl - Optimal

Method : Polyethylene glycol, PEG 100 - 129 mg/dl - Near/Above Optimal
130 - 159 mg/dl - Borderline high
160 - 189 mg/dl - High
>= 190 mg/dl - Very High

VLDL CHOLESTEROL 32.46 mg/dL 10 - 30

Method : Calculation

TRIGLYCERIDES 162.3 mg/dL Normal: < 161 mg/dL

Method : Enzymatic, end point High: 161 - 199 mg/dL
Hypertriglyceridemic: 200 - 499 mg/dL
Very High: > 499 mg/dL

CHOL:HDL RATIO 5 Upto 5.0

Method : Calculation

LDL:HDL RATIO 3.11

Note:

Checked By: K.VIJAY KUMAR

Lab Technician
______________________________________________________________________________________________________________________
**END OF REPORT**
Please Corelate With Clinical Findings If Necessary Discuss | * This is an Electronically Authenticated Report *

Printed On: Jan 25, 2025, 04:54 p.m. Page 5 of 9

Patient Name : Mr. M RAMESH Organization : SANJEEVANI CLINIC
Age / Gender : 58y / Male Sample ID : 250250174
Referred By : DR.SRINIVAS .K.MD Registered : Jan 25, 2025, 12:10 p.m.
Reg No : 1001782 Received On : Jan 25, 2025, 12:12 p.m.
Sample Type : SERUM Approved On : Jan 25, 2025, 03:37 p.m.

CLINICAL BIOCHEMISTRY

LIVER FUNCTION TEST (LFT)

TEST NAME(s) RESULTS UNITS REFERANCE RANGE

TOTAL BILIRUBIN 1.0 mg/dL 0.1 - 1.2

Method : Suphanilic Acid, DMSO

DIRECT BILIRUBIN* 0.21 mg/dL 0.0 - 0.2

Method : Diazontization

INDIRECT BILIRUBIN* 0.79 mg/dL 0.2 - 0.8

Method : Calculated

SERUM ALKALINE PHOSPHATASE* 86.1 IU/L Children : 104 - 390

Method : PNPP-AMP Buffer Adults : 25 - 140

SERUM SGOT(AST)* 25.6 U/L Up to 35

Method : UV, without P5P

SERUM SGPT(ALT)* 30.4 U/L Up to 45

Method : UV, without P5P

SERUM TOTAL PROTEINS 6.9 g/dL 6.4 - 8.3

Method : Biuret

ALBUMIN* 4.4 g/dL 3.5 - 5.2

Method : Bromocresol Green (BCG)

SERUM GLOBULIN* 2.50 g/dL 2.3 - 3.5

Method : calculated

A/G RATIO 1.76 1.0 - 2.0

Method : Calculated

Checked By: K.VIJAY KUMAR

Lab Technician
______________________________________________________________________________________________________________________
**END OF REPORT**
Please Corelate With Clinical Findings If Necessary Discuss | * This is an Electronically Authenticated Report *

Printed On: Jan 25, 2025, 04:54 p.m. Page 6 of 9

Patient Name : Mr. M RAMESH Organization : SANJEEVANI CLINIC
Age / Gender : 58y / Male Sample ID : 250250174
Referred By : DR.SRINIVAS .K.MD Registered : Jan 25, 2025, 12:10 p.m.
Reg No : 1001782 Received On : Jan 25, 2025, 12:12 p.m.
Sample Type : SERUM Approved On : Jan 25, 2025, 03:13 p.m.

HORMONES

THYROID STIMULATING HORMONE (TSH)

TEST NAME(s) RESULTS UNITS REFERANCE RANGE

TSH (ultra) 0.43 µIU/mL 1 - 4 days: 1.0 - 39.0 µIU/mL

Method : Chemiluminescence Immuno Assay (CLIA 5days - 6 months: 1.7 – 9.1 µIU/mL
7 months –17 years: 0.7 – 6.4 µIU/mL
Male 18 – 20 Years: 0.7 – 6.4 µIU/mL
Male 21 - 54 years : 0.4– 4.5 µIU/mL
Both 55 - 87 years : 0.4 – 4.5 µIU/mL
Female 18 – 20 Years: 0.7 – 6.4 µIU/mL
Female 21 - 54 years : 0.4– 4.5 µIU/mL
1st trimester : 0.3 - 4.5 µIU/mL
2nd trimester: 0.5 - 4.6 µIU/mL
3rd trimester : 0.8 - 5.2 µIU/mL

1. Serum TSH concentrations exhibit a diurnal variation with the peak occurring during the night.

2. Useful for:Screening for thyroid dysfunction and detecting mild (subclinical), as well as overt, primary hypo- or hyperthyroidism in ambulatory patients.
3. Monitoring patients on thyroid replacement therapy.
4. Confirmation of thyroid-stimulating hormone (TSH) suppression in thyroid cancer patients on thyroxine suppression therapy.
5.Prediction of thyrotropin-releasing hormone-stimulated TSH response.

Checked By: K.VIJAY KUMAR

Lab Technician
______________________________________________________________________________________________________________________
**END OF REPORT**
Please Corelate With Clinical Findings If Necessary Discuss | * This is an Electronically Authenticated Report *

Printed On: Jan 25, 2025, 04:54 p.m. Page 7 of 9

Patient Name : Mr. M RAMESH Organization : SANJEEVANI CLINIC
Age / Gender : 58y / Male Sample ID : 250250174
Referred By : DR.SRINIVAS .K.MD Registered : Jan 25, 2025, 12:10 p.m.
Reg No : 1001782 Received On : Jan 25, 2025, 12:12 p.m.
Sample Type : SERUM Approved On : Jan 25, 2025, 03:34 p.m.

CLINICAL BIOCHEMISTRY

URIC ACID (UA)

TEST NAME(s) RESULTS UNITS REFERANCE RANGE

URIC ACID 6.1 mg/dL Male : 3.49 - 7.19

Method : Uricase , POD Female : 2.6 - 6.0

INTERPRETATION
Purines are also created through the natural process of cell breakdown in the body. Most uric acid is dissolved in the blood, filtered through the kidneys, and
expelled in the urine

Checked By: K.VIJAY KUMAR

Lab Technician
______________________________________________________________________________________________________________________
**END OF REPORT**
Please Corelate With Clinical Findings If Necessary Discuss | * This is an Electronically Authenticated Report *

Printed On: Jan 25, 2025, 04:54 p.m. Page 8 of 9

Patient Name : Mr. M RAMESH Organization : SANJEEVANI CLINIC
Age / Gender : 58y / Male Sample ID : 250250174
Referred By : DR.SRINIVAS .K.MD Registered : Jan 25, 2025, 12:10 p.m.
Reg No : 1001782 Received On : Jan 25, 2025, 12:12 p.m.
Sample Type : SERUM Approved On : Jan 25, 2025, 03:51 p.m.

CLINICAL BIOCHEMISTRY

CREATININE SERUM

TEST NAME(s) RESULTS UNITS REFERANCE RANGE

Creatinine : 0.91 mg/dL Female : 0.6 - 1.2 mg/dL

Method : Jaffe's Method Male : 0.6 - 1.4 mg/dL
Interpretation :
The Creatinine test is conducted on the patient’s blood sample to test the levels of Creatinine. Creatinine is a waste product that is produced when creatine is
broken down. Abnormal levels of Creatinine could hint at dysfunctional kidneys.

Checked By: K.VIJAY KUMAR

Lab Technician
______________________________________________________________________________________________________________________
**END OF REPORT**
Please Corelate With Clinical Findings If Necessary Discuss | * This is an Electronically Authenticated Report *

Printed On: Jan 25, 2025, 04:54 p.m. Page 9 of 9